GIACCA, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 37.874
EU - Europa 16.185
AS - Asia 14.845
SA - Sud America 2.145
AF - Africa 378
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 28
Totale 71.508
Nazione #
US - Stati Uniti d'America 37.543
SG - Singapore 5.260
PL - Polonia 4.533
CN - Cina 3.686
UA - Ucraina 2.226
IT - Italia 2.197
SE - Svezia 1.689
BR - Brasile 1.674
VN - Vietnam 1.664
HK - Hong Kong 1.583
FI - Finlandia 995
KR - Corea 888
FR - Francia 804
DE - Germania 768
GB - Regno Unito 663
RU - Federazione Russa 581
TR - Turchia 558
BG - Bulgaria 425
IE - Irlanda 419
IN - India 297
NL - Olanda 268
AR - Argentina 171
CA - Canada 150
JP - Giappone 141
CH - Svizzera 115
MX - Messico 112
BD - Bangladesh 111
MA - Marocco 106
ES - Italia 88
BE - Belgio 86
ID - Indonesia 85
EC - Ecuador 84
ZA - Sudafrica 81
AT - Austria 74
IQ - Iraq 69
SA - Arabia Saudita 56
VE - Venezuela 56
PH - Filippine 46
AU - Australia 45
CL - Cile 44
UZ - Uzbekistan 42
IR - Iran 39
PK - Pakistan 39
CO - Colombia 37
SN - Senegal 37
PT - Portogallo 36
EG - Egitto 33
CZ - Repubblica Ceca 32
KE - Kenya 31
GR - Grecia 29
PY - Paraguay 29
TW - Taiwan 29
TH - Thailandia 27
DZ - Algeria 25
JO - Giordania 25
RO - Romania 25
MY - Malesia 23
PE - Perù 23
AE - Emirati Arabi Uniti 22
LT - Lituania 22
NP - Nepal 22
EU - Europa 21
HU - Ungheria 19
IL - Israele 18
DK - Danimarca 16
TN - Tunisia 16
OM - Oman 15
UY - Uruguay 15
PA - Panama 14
DO - Repubblica Dominicana 13
AZ - Azerbaigian 12
KZ - Kazakistan 12
AL - Albania 11
ET - Etiopia 11
HR - Croazia 11
JM - Giamaica 11
NO - Norvegia 10
BO - Bolivia 9
CR - Costa Rica 9
KG - Kirghizistan 9
NG - Nigeria 9
AM - Armenia 7
GE - Georgia 7
PS - Palestinian Territory 7
A2 - ???statistics.table.value.countryCode.A2??? 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
LB - Libano 6
LV - Lettonia 6
MM - Myanmar 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
RS - Serbia 6
TT - Trinidad e Tobago 6
AO - Angola 5
BH - Bahrain 5
KW - Kuwait 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
EE - Estonia 4
Totale 71.439
Città #
Fairfield 4.608
Woodbridge 4.420
Warsaw 4.110
Ashburn 3.202
Houston 3.181
Ann Arbor 3.133
Singapore 2.913
Wilmington 2.052
Jacksonville 1.981
Seattle 1.927
Chandler 1.822
Hong Kong 1.544
Cambridge 1.530
San Jose 1.196
Hefei 918
Seoul 860
Princeton 782
Beijing 717
Boardman 649
Chicago 593
Trieste 581
Ho Chi Minh City 481
Izmir 467
Sofia 422
Dublin 407
Columbus 405
Hanoi 396
Zgierz 391
Lauterbourg 370
Helsinki 293
Los Angeles 285
Moscow 283
The Dalles 254
Buffalo 245
Dearborn 224
San Diego 221
Dallas 215
Santa Clara 193
Milan 177
Council Bluffs 164
Frankfurt am Main 154
São Paulo 146
Düsseldorf 133
New York 126
London 124
Shanghai 110
Munich 107
Falls Church 96
Phoenix 90
Nanjing 89
Tokyo 86
Des Moines 83
Casablanca 80
Brussels 73
Dong Ket 72
Da Nang 71
Haiphong 69
Guangzhou 68
Orem 64
Tianjin 62
Redwood City 59
Kunming 57
Jinan 55
Verona 54
Rome 52
Nuremberg 51
Norwalk 50
Bern 49
Rio de Janeiro 49
Amsterdam 48
Toronto 48
Vienna 47
Atlanta 45
Zurich 45
San Francisco 44
Turku 44
Bremen 43
Mestre 41
Montreal 41
Chennai 40
Belo Horizonte 39
Grafing 39
Hangzhou 39
Dakar 37
Tashkent 37
Pune 35
Quito 35
Brooklyn 34
Zhengzhou 34
Dhaka 33
Brasília 32
Washington 32
Fremont 31
Johannesburg 31
Redondo Beach 31
Kocaeli 30
Denver 29
Edinburgh 28
Mumbai 28
Stockholm 28
Totale 52.139
Nome #
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library 678
AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia 516
Unacylated ghrelin reduces skeletal muscle reactive oxygen species generation and inflammation and prevents high-fat diet-induced hyperglycemia and whole-body insulin resistance in rodents 508
Nuclear architecture dictates HIV-1 integration site selection 495
In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure 431
Laser Therapy Inhibits Tumor Growth in Mice by Promoting Immune Surveillance and Vessel Normalization 430
AAV vector encoding human VEGF165-transduced pectineus muscular flaps increase the formation of new tissue through induction of angiogenesis in an in vivo chamber for tissue engineering: A technique to enhance tissue and vessels in microsurgically engineered tissue 425
A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9 421
Miocardite, cardiomiopatia infiammatoria e perimiocardite: possiamo fare ordine? 403
Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo 399
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9 388
Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction 371
The innate immune system in chronic cardiomyopathy: A European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC 370
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 370
In vivo selection of novel biotherapeutics 367
Genome-wide RNAi screening identifies host restriction factors critical for in vivo AAV transduction 365
Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction 362
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells 361
Neuronal hemoglobin affects dopaminergic cells' response to stress 360
VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans 356
Common Regulatory Pathways Mediate Activity of MicroRNAs Inducing Cardiomyocyte Proliferation 354
Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation. 353
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure 351
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 349
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy 338
3D Carbon Nanotube-Based Composites for Cardiac Tissue Engineering 314
Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease 309
Notch pathway activation enhances cardiosphere in vitro expansion 309
Adipokines, Ghrelin and Obesity-Associated Insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome. 301
Identification of HSP90 inhibitors as a novel class of senolytics 296
n-3 PUFA dietary lipid replacement normalizes muscle mitochondrial function and oxidative stress through enhanced tissue mitophagy and protects from muscle wasting in experimental kidney disease 286
Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure 282
Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. 274
Carbon Nanotubes Promote Growth and Spontaneous Electrical Activity in Cultured Cardiac Myocytes 269
Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. 269
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 269
Expression profiling of angiogenic genes for the characterisation of colorectal carcinoma. 263
C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. 262
Imaging HIV-1 nuclear pre-integration complexes. 261
Cardiac regeneration and remodelling of the cardiomyocyte cytoarchitecture 260
Inducible adeno-associated virus vectors promote functional angiogenesis in adult organisms via regulated vascular endothelial growth factor expression 257
Evaluation of nutritional status in head and neck radio-treated patients affected by oral mucositis: efficacy of class IV laser therapy. 257
TBL1Y: a new gene involved in syndromic hearing loss 257
DOSE AND TIME-DEPENDENT APOPTOTIC EFFECTS BY ANGIOTENSIN II INFUSION ON LEFT VENTRICULAR CARDIOMYOCYTES. 253
A candidate approach implicates the secreted Salmonella effector protein SpvB in P-body disassembly. 253
Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice 253
High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation 252
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy 249
In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells 248
Sirt3 Deficiency Shortens Life Span and Impairs Cardiac Mitochondrial Function Rescued by Opa1 Gene Transfer 248
Chapter 11: Regenerative Medicine and Biomarkers for Dilated Cardiomyopathy 248
Single-Dose Intracardiac Injection of Pro-Regenerative MicroRNAs Improves Cardiac Function After Myocardial Infarction 247
Effect of vascular endothelial growth factor gene therapy on post-traumatic peripheral nerve regeneration and denervation-related muscle atrophy. 244
A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. 243
Functional screening identifies miRNAs inducing cardiac regeneration 242
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. 241
The renaissance of competitive PCR as an accurate tool for precise nucleic acid quantification. 241
Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. 233
Reversible Notch1 acetylation tunes proliferative signalling in cardiomyocytes 233
Endothelial cell-cardiomyocyte crosstalk in heart development and disease 233
Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs 232
Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels 230
A novel myogenic cell line with phenotypic properties of muscle progenitors 230
Idiopathic dilated cardiomyopathy and persistent viral infection: Lack of association in a controlled study using a quantitative assay. 230
Microsurgical arterovenous loops and biological templates: a novel in vivo chamber for tissue engineering. 229
Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease. 229
Adeno-Associated Virus Vectors as Therapeutic and Investigational Tools in the Cardiovascular System. 229
Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome. 228
Supporting data on in vitro cardioprotective and proliferative paracrine effects by the human amniotic fluid stem cell secretome 228
A rapid procedure for the quantitation of low abundance RNAs by competitive reverse transcription-polymerase chain reaction 226
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. 225
AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo 224
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 221
Genetic lineage tracing reveals poor angiogenic potential of cardiac endothelial cells 220
Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. 219
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. 218
Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system 217
In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature 215
Intracoronary gene delivery of the cytoprotective factor vascular endothelial growth factor-B167 in canine patients with dilated cardiomyopathy: A short-term feasibility study 215
Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome 213
Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects. 212
A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. 212
A quantitative procedure for monitoring expression of human immuno deficiency virus type 1. 211
Plasma total and unacylated ghrelin predict 5-year changes in insulin resistance 211
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 211
Anti-idiotypic response in mice expressing human autoantibodies. 208
Development of antibody fragments for immunotherapy of prion diseases. 208
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection 208
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. 207
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. 206
Transcellular protein transduction using the Tat protein of HIV-1. 204
High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation 204
HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium 203
Improved survival of ischemic cutaneous and musculocutaneous flaps after VEGF gene transfer using AAV vectors 202
Adeno-associated virus vectors: versatile tools for in vivo gene transfer. 202
Inhibition of heterologous DNA replication by the MVMp nonstructural NS-1 protein: identification of a target sequence. 202
Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. 201
An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology 200
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 200
Macrophage microRNA-155 promotes cardiac hypertrophy and failure. 199
Totale 27.866
Categoria #
all - tutte 196.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.776 0 0 0 0 0 0 0 0 0 812 298 666
2021/20224.300 237 337 233 335 78 392 238 158 575 495 328 894
2022/20235.379 599 500 434 728 566 1.121 33 408 624 41 229 96
2023/20243.123 233 244 124 190 290 218 422 643 34 99 296 330
2024/20257.481 213 313 478 657 758 904 432 588 965 834 612 727
2025/202617.183 1.319 1.280 1.602 1.881 1.435 1.908 2.792 719 2.150 2.097 0 0
Totale 72.522